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doi: 10.1016/j.bpj.2012.04.046Leucine-rich repeat kinase 2 (LRRK2) is a large (2527
amino acids) multidomain protein that contains enzymati-
cally functional GTPase and kinase domains (1–6).
Missense point mutations in LRRK2 are the most common
cause of familial Parkinson’s disease (PD) (7). The molec-
ular mechanisms by which LRRK2 mutations cause PD
remain uncertain. In vitro studies are consistent with a toxic
gain-of-function mechanism that is dependent upon LRRK2
kinase activity (1–5). This possibility suggests that LRRK2-
specific kinase inhibitors may have therapeutic benefit.
LRRK2 kinase activity has been reported to be dependent
upon LRRK2 dimerization (8) and inhibiting LRRK2 dimer-
ization may be a good alternative therapeutic approach.
However, Ito and Iwatsubo (9) have recently reported that
LRRK2 is predominantly monomeric and that dimerization
is dispensable for LRRK2 enzymatic activity. Because
previous studies have analyzed LRRK2 in vitro, it is impor-
tant to determine the oligomeric state(s) of LRRK2 in living
cells, which remains a key unanswered question.
Evidence for potential LRRK2 oligomerization was
initially obtained using tandem affinity purification (10) as
well as by yeast two-hybrid analysis and by coprecipitation
of differentially tagged LRRK2 fragments from transfected
cells (11). Subsequent analyses of LRRK2 oligomerization
have employed classical biochemical techniques. For
example, Greggio et al. (11) and Sen et al. (8) estimated
that LRRK2 is primarily dimeric, based on size-exclusion
chromatography and native PAGE extracts from LRRK2
overexpressing cells. Berger et al. (12) used a combinationof techniques, including density gradient centrifugation,
size-exclusion chromatography, and native gel electropho-
resis, to demonstrate that LRRK2 extracted from cell
membranes is both monomeric and dimeric, whereas cyto-
solic fractions contain almost exclusively monomeric
LRRK2.
By contrast, Jorgensen et al. (13) found no evidence of
LRRK2 monomer in cell lysates analyzed by size exclusion
chromatography and blue native gel electrophoresis.
However, as mentioned, Ito and Iwatsubo (9) reported, based
on density gradient centrifugation, that LRRK2 is predomi-
nantly monomeric. Although these studies have provided
valuable information regarding LRRK2 self-association
and its potential physiological significance, they have relied
exclusively on in vitro analyses of cell extracts, which may
account for some of the conflicting conclusions. Here we
apply number and brightness (N&B) analysis of fluores-
cence fluctuation spectroscopy data to directly measure
LRRK2 oligomerization in the cytoplasm and membranes
of living cells.
CHO-K1 cells were transfected using a pCMV vector
(Clontech, Mountain View, CA) engineered to express
EGFP fused to the N-terminus of wild-type mouse
LRRK2. The EGFP coding sequence contained an A207K
L42 Biophysical Lettersmutation to eliminate potential dimerization of the EGFP
moiety. Confocal images were collected 24 h after transfec-
tion, using a Fluoview 1000 microscope (Olympus, Mel-
ville, NY) in the photon-counting mode, with EGFP
excitation from the 488-nm line of an Argon-ion laser
(scan speed 12.5 ms/pixel, scan area 256 256 pixels). Total
internal reflection fluorescence (TIRF) measurements were
conducted with an instrument previously described by
Unruh and Gratton (14) and Ross et al. (15) using 50-ms
exposure time per frame. N&B analysis allows for the deter-
mination of the number (N) of diffusing particles within the
focal spot and the intrinsic brightness (B) of each particle,
N ¼ ðhIi  offsetÞ
2
s2  s20
; B ¼ s
2  s20
hIi  offset
where I is the signal intensity, s2 is the variance, and offset
and s0
2 are the intensity offset and readout noise variance of
the detection electronics, respectively. N&B provides a map
of number and brightness for every pixel in the image by
calculating the average and variance of the intensity distri-
bution in each pixel (16,17).
In the TIRF system, with an analog camera, both the
offset and gain must be calibrated in terms of the digital
level/counts (14). A separate set of CHO-K1 cells trans-
fected with monomeric EGFP and monomeric EGFP fused
to the membrane targeting sequence GAP-43 were used as
the brightness standards for confocal and TIRF experiments,
respectively.
Fig. 1 A shows a representative image of a CHO-K1 cell
transfected with EGFP-LRRK2. The focal plane was posi-
tioned just above the nucleus, as EGFP-LRRK2 is not found
in the nucleus (data not shown). The fluorescence intensity
levels varied throughout the cell, indicative of LRRK2
localization. Using N&B analysis (Fig. 1 B), and normal-
izing the brightness levels using the monomeric EGFP stan-
dard (B value ¼ 1.09), one finds that the green pixels
correspond to the brightness values of monomeric EGFPFIGURE 1 (A) Confocal intensity image of EGFP-LRRK2. (B) Brightn
box) and higher-order oligomers (red box). (C) Brightness map highl
and higher-order oligomers (red). Bars equal 15 mm.
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approximately three times the monomeric level. The red
pixels may represent a combination of dimer and tetramer
or some other combination of higher oligomers. The bright-
ness plot shown in Fig. 1 C indicates that much of the cyto-
solic EGFP-LRRK2 was present in the monomeric state
(green pixels in Fig. 1 C) whereas most of the higher-order
oligomeric states (red pixels in Fig. 1 C) were found near the
cell periphery (~84% of the pixels, analyzed from two cells,
corresponded to monomeric EGFP-LRRK2).
The presence of higher oligomeric states in the plasma
membrane of the cells was verified using TIRF microscopy
(Fig. 2). The density of EGFP-LRRK2 varied in the plasma
membrane, with some distinct areas of more concentrated
LRRK2. N&B analysis reveals that the oligomeric state
of EGFP-LRRK2 was heterogeneous on the plasma
membrane, though it was predominately oligomeric
(~80% of the pixels analyzed, from two cells, corresponded
to oligomeric states greater than monomer). In Fig. 2 C the
green pixels correspond to monomeric brightness levels
(B value ¼ 1.06 for standard) while the red and blue pixels
correspond to dimer brightness levels and higher-order olig-
omers, respectively. We note that the pixels with very low
intensities surrounding the cell were not included because
these were judged to correspond to parts of the plasma
membrane that were not adhering to the surface, i.e., which
were raised slightly off the substrate, and hence in a weaker
portion of the illumination field.
Our confocal data demonstrate that the oligomeric state of
LRRK2 in living cells depends on the subcellular localiza-
tion. We observed a distribution of predominately LRRK2
monomers in the cytosol whereas the confocal/TIRF analysis
is consistent with a distribution of predominately higher-
order (e.g., dimers and tetramers) oligomeric states of
LRRK2 on the plasma membrane. Biochemical studies
have shown that the dimer form of LRRK2 has greater kinase
activity than monomeric LRRK2 and that membrane frac-
tions of cell lysates are enriched with LRRK2 dimeress versus intensity plot showing the monomeric LRRK2 (green
ighting the regions within the cells containing monomer (green)
FIGURE 2 (A) TIRF intensity image of EGFP-LRRK2. (B) Brightness-versus-intensity plot showing the monomeric LRRK2 (green
box), dimeric LRRK2 (red box), and the higher-order oligomers (blue box). (C) Brightness map highlighting the regions containing
monomer (green), dimer (red), and higher-order oligomers (blue). Bars equal 17 mm.
Biophysical Letters L43(6,12). These data and our N&B analysis support a model of
LRRK2 in which the protein cycles between a low-activity
monomeric state and high-activity multimeric (dimer and/or
higher) states. Predominantly monomeric LRRK2 in the
cytosol can be recruited to the plasma membrane, either
directly or indirectly, through a regulatory mechanism yet
defined. Association with the plasma membrane increases
local concentration and presumably induces self-association.
The use of in vivo fluorescence fluctuation analysis allows
us to address the oligomeric states of the PD-linked protein
LRRK2 in living cells. In particular, we demonstrate for the
first time (to our knowledge) that the LRRK2 protein can
exist in oligomeric forms on the plasma membrane of living
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